🔎 Trials Near Me

Home › Graves Disease

Graves Disease clinical trials recruiting in the U.S.

15 studies for Graves Disease are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07570316

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 17, 2026 · NCT07661056

Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07682896

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Aug 24, 2026 · NCT07305818

Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT07753603

Preoperative Corticosteroids in Autoimmune Thyroid Disease

RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT05435547

Study of BHV-1300 in Graves' Disease

RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jul 31, 2026 · NCT06980649

Telehealth Music Therapy for Adults With Endocrine Disorder and Depression

Recruiting
Ages 18 to 65 · All sexes · Updated Jul 30, 2026 · NCT07413874

Evaluating an AI Tool for Detecting Thyrotoxic States

RecruitingObservational study
Ages 22 and older · All sexes · Updated Jun 1, 2026 · NCT07017907

Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease

RecruitingPhase 2
Ages 9 to 17 · All sexes · Updated Jan 27, 2026 · NCT07369063

Personalized Treatment in Thyroid Disorders

Recruiting
Ages 21 to 65 · All sexes · Updated Oct 15, 2025 · NCT03517579

The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction

RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 23, 2024 · NCT06275373

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.